Patient-Centered Treatment Strategies in the Management of nAMD and DME episode artwork

EPISODE · May 30, 2025 · 13 MIN

Patient-Centered Treatment Strategies in the Management of nAMD and DME

from EyePod · host Ophthalmology Times

Recently approved anti-VEGF agents that target additional pathways and offer innovative delivery methods with longer-lasting effects may provide advantages over older anti-VEGF agents in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this podcast, expert faculty discuss the roles of ophthalmologists and optometrists in managing nAMD and DME in an evolving treatment landscape, from screening and diagnosis to referral and ongoing patient care.

Episode metadata supplied by the publisher feed · Published May 30, 2025

Embed this episode

NOW PLAYING

Patient-Centered Treatment Strategies in the Management of nAMD and DME

0:00 13:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of EyePod?

This episode is 13 minutes long.

When was this EyePod episode published?

This episode was published on May 30, 2025.

Can I download this EyePod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!